Uncontrolled Wet AMD: Drug Switch Can Mute Disease Activity
Phase 3 data from the 2023 ARVO meeting showed treatment with the monoclonal antibody improved visual acuity in some patients.
Medscape Medical News
source https://www.medscape.com/viewarticle/991143?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/991143?src=rss
Comments
Post a Comment